{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-21-000413","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.846288+00:00","generated_at":"2026-06-28T12:38:48.027925+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Globus Medical Q3 2021 revenue up 6.3% to $229.7M; GAAP EPS $0.45, non-GAAP $0.50; FY guidance reaffirmed","bullets":["Worldwide net sales $229.7M (+6.3% YoY); US sales +8.8%, International -7.2%.","GAAP net income $47.2M (20.6% of sales); GAAP diluted EPS $0.45 vs $0.44; non-GAAP diluted EPS $0.50 vs $0.49.","Non-GAAP adjusted EBITDA $78.3M (34.1% of sales); operating cash flow $77.3M; free cash flow $59.5M.","Cash, equivalents and marketable securities $985M; debt-free. FY2021 guidance reaffirmed: net sales $950M, non-GAAP diluted EPS $2.00.","CEO cites market share gains, Enabling Technology momentum, best recruiting quarter, and FDA clearances for Excelsius3D and ExcelsiusHUB."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-21-000413","json":"https://secwatch.observer/filing/0001562762-21-000413.json","markdown":"https://secwatch.observer/filing/0001562762-21-000413.md","text":"https://secwatch.observer/filing/0001562762-21-000413.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000156276221000413/0001562762-21-000413-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000156276221000413/gmed-20211104x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:38:48.027925+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}